Latest Gonadotropin-releasing hormone antagonist Stories

2009-02-03 15:05:00

SAN DIEGO, Feb. 3 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the fourth quarter and year ended December 31, 2008. For the three months ended December 31, 2008, the Company reported a net loss of $28.9 million or $0.75 loss per share compared to a net loss of $128.0 million or $3.35 loss per share for the same period last year. For the year ended December 31, 2008, the Company had a net loss of $88.6 million or $2.30 loss per...

2008-12-03 13:24:14

Degarelix avoids initial hormone surge seen in other drugsMore than 95 per cent of men who took degarelix for prostate cancer saw their testosterone levels fall dramatically as early as three days after they started treatment, according to a paper in the December issue of BJU International.They also experienced much greater falls in their prostate-specific antigen (PSA) levels at 14 and 28 days than men taking leuprolide.Researchers from Canada, the USA, France, Denmark and the Netherlands...

2006-01-30 12:15:00

NEW YORK -- For women with endometriosis who undergo assisted fertilization procedures, treatment with a hormone that decreases the body's production of testosterone and estrogen a few months before the procedure quadruples the chance of successful pregnancy, according to a review of randomized trials -- but data on side effects is lacking. Endometriosis is a painful condition that occurs when the tissue that normally lines the uterus grows outside the uterus, often in pelvic and abdominal...

Word of the Day
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'